A Randomized, Double-Blind, Placebo-controlled Study of SD-809 (Dutetrabenazine) for the Treatement of Moderate to Severe Tardive Dyskinesia

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2014 - June 30, 2016